BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30890783)

  • 1. Atlas-CNV: a validated approach to call single-exon CNVs in the eMERGESeq gene panel.
    Chiang T; Liu X; Wu TJ; Hu J; Sedlazeck FJ; White S; Schaid D; Andrade M; Jarvik GP; Crosslin D; Stanaway I; Carrell DS; Connolly JJ; Hakonarson H; Groopman EE; Gharavi AG; Fedotov A; Bi W; Leduc MS; Murdock DR; Jiang Y; Meng L; Eng CM; Wen S; Yang Y; Muzny DM; Boerwinkle E; Salerno W; Venner E; Gibbs RA
    Genet Med; 2019 Sep; 21(9):2135-2144. PubMed ID: 30890783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VisCap: inference and visualization of germ-line copy-number variants from targeted clinical sequencing data.
    Pugh TJ; Amr SS; Bowser MJ; Gowrisankar S; Hynes E; Mahanta LM; Rehm HL; Funke B; Lebo MS
    Genet Med; 2016 Jul; 18(7):712-9. PubMed ID: 26681316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent count region-copy number variation (CCR-CNV): an expandable and robust tool for clinical diagnosis of copy number variation at the exon level using next-generation sequencing data.
    Kim MJ; Lee S; Yun H; Cho SI; Kim B; Lee JS; Chae JH; Sun C; Park SS; Seong MW
    Genet Med; 2022 Mar; 24(3):663-672. PubMed ID: 34906491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of exon-level copy number variants in CytoScan XON assay and next-generation sequencing in clinical samples.
    Won D; Yeom E; Shin S; Lee ST; Rak Choi J
    Clin Chim Acta; 2024 Jun; 560():119703. PubMed ID: 38763467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
    Fowler A; Mahamdallie S; Ruark E; Seal S; Ramsay E; Clarke M; Uddin I; Wylie H; Strydom A; Lunter G; Rahman N
    Wellcome Open Res; 2016 Nov; 1():20. PubMed ID: 28459104
    [No Abstract]   [Full Text] [Related]  

  • 7. Accuracy of CNV Detection from GWAS Data.
    Zhang D; Qian Y; Akula N; Alliey-Rodriguez N; Tang J; ; Gershon ES; Liu C
    PLoS One; 2011 Jan; 6(1):e14511. PubMed ID: 21249187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
    Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
    BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of copy number variants from exome sequence data.
    Samarakoon PS; Sorte HS; Kristiansen BE; Skodje T; Sheng Y; Tjønnfjord GE; Stadheim B; Stray-Pedersen A; Rødningen OK; Lyle R
    BMC Genomics; 2014 Aug; 15(1):661. PubMed ID: 25102989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.
    Corsini S; Pedrini E; Patavino C; Gnoli M; Lanza M; Sangiorgi L
    Front Endocrinol (Lausanne); 2022; 13():874126. PubMed ID: 35837302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
    Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
    Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DeviCNV: detection and visualization of exon-level copy number variants in targeted next-generation sequencing data.
    Kang Y; Nam SH; Park KS; Kim Y; Kim JW; Lee E; Ko JM; Lee KA; Park I
    BMC Bioinformatics; 2018 Oct; 19(1):381. PubMed ID: 30326846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
    Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
    BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy Number Variation detection from 1000 Genomes Project exon capture sequencing data.
    Wu J; Grzeda KR; Stewart C; Grubert F; Urban AE; Snyder MP; Marth GT
    BMC Bioinformatics; 2012 Nov; 13():305. PubMed ID: 23157288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive performance comparison of high-resolution array platforms for genome-wide Copy Number Variation (CNV) analysis in humans.
    Haraksingh RR; Abyzov A; Urban AE
    BMC Genomics; 2017 Apr; 18(1):321. PubMed ID: 28438122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of copy number variation detection for a SNP array platform.
    Zhang X; Du R; Li S; Zhang F; Jin L; Wang H
    BMC Bioinformatics; 2014 Feb; 15():50. PubMed ID: 24555668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SavvyCNV: Genome-wide CNV calling from off-target reads.
    Laver TW; De Franco E; Johnson MB; Patel KA; Ellard S; Weedon MN; Flanagan SE; Wakeling MN
    PLoS Comput Biol; 2022 Mar; 18(3):e1009940. PubMed ID: 35294448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Copy Number Variant Detection from Sequencing Data with a Combination of Programs and a Predictive Model.
    Välipakka S; Savarese M; Sagath L; Arumilli M; Giugliano T; Udd B; Hackman P
    J Mol Diagn; 2020 Jan; 22(1):40-49. PubMed ID: 31733349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ICR96 exon CNV validation series: a resource for orthogonal assessment of exon CNV calling in NGS data.
    Mahamdallie S; Ruark E; Yost S; Ramsay E; Uddin I; Wylie H; Elliott A; Strydom A; Renwick A; Seal S; Rahman N
    Wellcome Open Res; 2017; 2():35. PubMed ID: 28630945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNV analysis in a diagnostic setting using target panel.
    Sorrentino E; Daja M; Cristofoli F; Paolacci S; Bertelli M; Marceddu G
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):7-13. PubMed ID: 34890029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.